application): In this proposal the applicant seeks to develop a new technology to allow genetic scaffolding of multiple different chemical moieties. These molecules are referred to as morphatides. The feasibility of selecting morphatides with high affinity for the targets (thrombin and Rnase A) will be assessed. Reiterative rounds of coupling, selection and amplification will be utilized to improve the interactive ability of the morphatides. If successful, this approach will greatly simplify and expand the ability to isolate small molecules that can be utilized as reagents to probe molecular pathways, or as clinical imaging, targeting, or therapeutic agents.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43DK053157-01A1
Application #
2644107
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (01))
Program Officer
Beisler, John A
Project Start
1998-06-01
Project End
1998-11-30
Budget Start
1998-06-01
Budget End
1998-11-30
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Invitrogen Corporation
Department
Type
DUNS #
City
Carlsbad
State
CA
Country
United States
Zip Code
92008